Carrington Subsidiary Delsite Biotechnologies Extends Commercial Evaluation License Agreement With NIH for Typhoid Vaccine
16 mai 2008 10h22 HE
|
DelSite, Inc.
IRVING, Texas, May 16, 2008 (PRIME NEWSWIRE) -- Carrington Laboratories, Inc. (OTCBB:CARN) today announced its wholly-owned subsidiary, DelSite Biotechnologies, Inc., has extended its Commercial...
Carrington Reports First Quarter 2008 Results
15 mai 2008 08h29 HE
|
DelSite, Inc.
Major Shift in Business Strategy Puts Singular Focus On Vaccine,
Drug Delivery and Adjuvant Technologies
Conference Call Scheduled for 4:30 pm Eastern Today
IRVING,...